| Literature DB >> 28149320 |
Marc-Andreas Edel1, Brian Blackwell1, Markus Schaub2, Barbara Emons2, Tanja Fox1, Friederike Tornau2, Bernward Vieten3, Patrik Roser1, Ida Sibylle Haussleiter1,2, Georg Juckel1,2.
Abstract
BACKGROUND: Despite marked costs and limited evidence regarding effectiveness, occupational therapy (OT) is widely applied in psychiatric settings and financed by health insurance companies in European countries. This pilot study investigated the antidepressive effects of adjuvant OT for patients with major depression in a 6-week inpatient setting, stratified for females and males.Entities:
Keywords: Adjuvant occupational therapy; Antidepressive effects; Major depression
Year: 2017 PMID: 28149320 PMCID: PMC5273796 DOI: 10.1186/s12991-016-0124-0
Source DB: PubMed Journal: Ann Gen Psychiatry ISSN: 1744-859X Impact factor: 3.455
Group comparisons (demographic and clinical data)
| Occupational therapy | Board game group | Chi squarea/tb | df |
| |
|---|---|---|---|---|---|
| Demographic data | |||||
| |
|
| |||
| Sex (f:m) | 26:20 | 18:18 | 0.38a | 1 | 0.539 |
| Age, years (SD) | 46.8 (11.8) | 44.8 (11.7) | 0.84b | 81.8 | 0.401 |
| Age, females (SD) | 45.7 (10.7) | 45.4 (13.3) | 0.11b | 40.4 | 0.910 |
| Age, males (SD) | 48.2 (13.3) | 44.1 (9.8) | 1.18b | 31.5 | 0.247 |
| Age groups | 6 groups ranging from 18 to 70 years of age | 2.74a | 5 | 0.740 | |
| Educational level | 11 categories ranging from ‘no degree’ to ‘university degree’ | 17.3a | 10 | 0.068 | |
| Marital status | 4 categories (single, married, divorced, widowed) | 577a | 3 | 0.124 | |
| Clinical data | |||||
| Intelligence, MWT-B, raw data (SD) | 29.1 (14.8) | 28.1 (4.8) | 0.50b | 71.2 | 0.617 |
| Intelligence, females (SD) | 30.3 (9.0) | 27.7 (4.7) | 0.77b | 37.7 | 0.448 |
| Intelligence, males (SD) | 27.5 (4.8) | 28.5 (5.0) | −0.70b | 37 | 0.487 |
| Axis-I disorders (SD) | 1.7 (0.8) | 1.5 (0.7) | 0.18b | 75 | 0.861 |
| Axis-I disorders, females (SD) | 1.8 (0.9) | 1.4 (0.6) | 1.62b | 35.8 | 0.112 |
| Axis-I disorders, males (SD) | 1.3 (0.6) | 1.7 (0.8) | −1.74b | 36 | 0.090 |
| Axis-II disorders (SD) | 0.2 (0.4) | 0.1 (0.3) | 0.60b | 75 | 0.550 |
| Axis-II disorders, females (SD) | 0.2 (0.4) | 0.1 (0.3) | 0.22b | 39.7 | 0.827 |
| Axis-II disorders, males (SD) | 0.2 (0.4) | 0.1 (0.3) | 0.64b | 36 | 0.524 |
| Number of psychoactive drugs (SD) | 2.6 (1.4) | 2.4 (1.3) | 0.63b | 72 | 0.529 |
| Number of psychoactive drugs, females (SD) | 2.6 (1.3) | 2.0 (0.8) | 2.40b | 42 | 0.020 |
| Number of psychoactive drugs, males (SD) | 2.4 (1.4) | 2.9 (1.8) | −0.99b | 36 | 0.331 |
| Number of antidepressants (SD) | 1.8 (1.0) | 1.7 (0.8) | 0.20b | 77.8 | 0.848 |
| Number of antidepressants, females (SD) | 1.8 (0.8) | 1.6 (0.8) | 1.02b | 38.7 | 0.311 |
| Number of antidepressants, males (SD) | 1.7 (1.2) | 1.9 (0.72) | −0.64b | 36 | 0.524 |
a relates to Pearson's Chi-square tests
b relates to t tests
Occupational therapy (n = 46) vs. board games (n = 36): general linear model (significant interaction effects at baseline and after 3 weeks)
| Variable | Subgroup | GLM | Means, differences (pre-post) and effect sizes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Within-subject effects (time) | Between-subjects effects (group) | Interaction (time × group) | Occupational therapy | Board game group | |||||||||||
| F |
| F |
| F |
| M pre (SD) | M post (SD) | ∆Mpre-Mpost | ES | M pre (SD) | M post (SD) | ∆Mpre-Mpost | ES | ||
| BDI 12 | Total | 0.429 | 0.515 | 4.579 | 0.036 | 1.001 | 0.298 | 1.21 (0.87) | 0.83 (0.74) | 0.38 | 0.47 | 0.83 (0.75) | 0.65 (0.65) | 0.18 | 0.26 |
| m | 0.010 | 0.922 | 1.237 | 0.276 | 13.494 | 0.001 | 1.25 (0.90) | 0.53 (0.61) | 0.72 | 0.95 | 0.53 (0.70) | 0.81 (0.75) | – | – | |
| f | 0.000 | 0.992 | 2.445 | 0.128 | 2.559 | 0.119 | 1.18 (0.86) | 1.04 (0.76) | 0.14 | 0.16 | 1.10 (0.70) | 0.50 (0.51) | 0.60 | 0.98 | |
| BDI 16 | Total | 0.003 | 0.954 | 0.769 | 0.376 | 4.983 | 0.029 | 1.63 (1.09) | 1.30 (1.07) | 0.33 | 0.31 | 1.90 (1.01) | 1.06 (0.81) | 0.84 | 0.92 |
| m | 0.000 | 0.991 | 3.057 | 0.092 | 1.047 | 0.315 | 1.50 (1.02) | 1.16 (1.07) | 0.34 | 0.32 | 2.00 (1.08) | 1.13 (0.72) | 0.87 | 0.97 | |
| f | 0.006 | 0.937 | 0.006 | 0.938 | 1.607 | 0.214 | 1.75 (1.14) | 1.41 (1.08) | 0.34 | 0.31 | 1.82 (0.96) | 1.00 (0.91) | 0.82 | 0.87 | |
| BDI 22 | Total | 0.481 | 0.490 | 0.000 | 0.993 | 3.094 | 0.083 | 1.52 (1.16) | 1.33 (1.12) | 0.19 | 0.17 | 1.37 (1.20) | 1.47 (1.16) | – | – |
| m | 2.190 | 0.150 | 0.493 | 0.489 | 5.017 | 0.034 | 1.54 (1.06) | 1.00 (1.00) | 0.54 | 0.52 | 1.30 (1.13) | 1.55 (1.13) | – | – | |
| f | 0.022 | 0.883 | 0.271 | 0.606 | 0.150 | 0.702 | 1.50 (1.26) | 1.56 (1.16) | – | – | 1.43 (1.29) | 1.55 (1.29) | – | – | |
| HAMA total | Total | 0.635 | 0.428 | 5.715 | 0.020 | 1.291 | 0.260 | 20.07 (7.06) | 12.86 (6.73) | 7.21 | 1.04 | 20.95 (6.75) | 16.60 (8.78) | 4.35 | 0.56 |
| m | 0.023 | 0.882 | 4.511 | 0.044 | 5.226 | 0.031 | 19.38 (7.56) | 10.94 (5.07) | 8.52 | 1.23 | 19.11 (5.61) | 16.35 (5.78) | 2.76 | 0.48 | |
| f | 0.108 | 0.744 | 2.060 | 0.160 | 0.120 | 0.731 | 20.58 (6.75) | 14.12 (7.45) | 6.46 | 0.91 | 22.55 (7.34) | 16.83 (11.07) | 5.72 | 0.62 | |
| HAMA 6 | Total | 0.230 | 0.633 | 3.001 | 0.088 | 4.190 | 0.044 | 2.81 (0.64) | 1.84 (0.97) | 0.97 | 1.20 | 2.83 (0.71) | 2.23 (0.81) | 0.60 | 0.79 |
| m | 0.023 | 0.880 | 0.305 | 0.586 | 3.669 | 0.067 | 2.88 (0.45) | 1.88 (0.86) | 1.00 | 1.52 | 2.74 (0.56) | 2.24 (0.66) | 0.50 | 0.82 | |
| f | 0.010 | 0.919 | 2.156 | 0.151 | 0.189 | 0.666 | 2.76 (0.75) | 1.81 (1.06) | 0.95 | 1.04 | 2.91 (0.87) | 2.22 (0.94) | 0.69 | 0.77 | |
| PSP C | Total | 0.000 | 0.991 | 1.309 | 0.256 | 1.908 | 0.171 | 1.20 (0.56) | 1.16 (0.42) | 0.04 | 0.08 | 1.36 (0.62) | 1.17 (0.51) | 0.19 | 0.33 |
| m | 0.835 | 0.368 | 0.283 | 0.599 | 0.013 | 0.911 | 1.33 (0.76) | 1.21 (0.54) | 0.12 | 0.18 | 1.35 (0.59) | 1.22 (0.55) | 0.13 | 0.36 | |
| f | 1.400 | 0.245 | 3.341 | 0.076 | 5.213 | 0.029 | 1.10 (0.30) | 1.12 (0.33) | – | – | 1.36 (0.66) | 1.11 (0.47) | 0.25 | 0.44 | |
BDI 12: loss of interest
BDI 16: disturbed sleep pattern
BDI 22: loss of sexual interest
HAMAtotal: total score
HAMA 6: depressed mood
PSP C: self-care
GLM general linear model (controlled for age, IQ, axis-I/II comorbidity, number of psychoactive drugs and number of antidepressants), stratified for gender (m males, f females); M pre/post mean pre/post, SD standard deviation, ∆ difference between re- and post-mean, ES effect size (Cohen’s d). BDI Beck Depression Inventory, HAMA Hamilton Anxiety Scale, PSP Personal and Social Performance Scale
Occupational therapy (n = 29) vs. board games (n = 22): general linear model (significant interaction effects at baseline and after 6 weeks)
| Variable | Sub-group | GLM | Means, differences (pre-post) and effect sizes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Within-subject effects (time) | Between-subjects effects (group) | Interaction (time × group) | Occupational therapy | Board game group | |||||||||||
| F |
| F |
| F |
| M pre (SD) | M post (SD) | ∆Mpre-Mpost | ES | M pre (SD) | M post (SD) | ∆Mpre-Mpost | ES | ||
| HAMD 19 | Total | 3.682 | 0.062 | 2.500 | 0.121 | 4.321 | 0.044 | 0.02 (0.13) | 0.03 (0.19) | – | – | 0.12 (0.33) | 0.00 (0.00) | 0.12 | 0.71 |
| m | 1.814 | 0.194 | 3.291 | 0.085 | 4.944 | 0.039 | 0.00 (0.00) | 0.06 (0.25) | – | – | 0.10 (0.31) | 0.00 (0.00) | 0.10 | 0.63 | |
| f | 1.003 | 0.331 | 2.509 | 0.132 | 2.509 | 0.132 | 0.03 (0.17) | 0.00 (0.00) | 0.03 | 0.33 | 0.14 (0.35) | 0.00 (0.00) | 0.14 | 0.78 | |
| BDI 15 | Total | 0.290 | 0.594 | 0.060 | 0.808 | 5.095 | 0.030 | 1.88 (0.70) | 1.11 (0.75) | 0.77 | 1.05 | 1.67 (0.85) | 1.25 (0.97) | 0.42 | 0.46 |
| m | 1.452 | 0.245 | 0.202 | 0.659 | 0.928 | 0.349 | 1.88 (0.68) | 1.06 (0.77) | 0.82 | 1.12 | 1.65 (0.75) | 1.11 (0.93) | 0.56 | 0.67 | |
| f | 0.025 | 0.877 | 0.850 | 0.373 | 0.757 | 0.400 | 1.89 (0.74) | 1.18 (0.75) | 0.71 | 0.95 | 1.68 (0.95) | 1.36 (1.03) | 0.32 | 0.32 | |
| BDI 16 | Total | 0.008 | 0.930 | 7.164 | 0.011 | 0.555 | 0.461 | 1.63 (1.09) | 0.81 (0.74) | 0.82 | 0.89 | 1.90 (1.01) | 1.43 (1.17) | 0.47 | 0.43 |
| m | 1.205 | 0.287 | 7.065 | 0.016 | 0.075 | 0.787 | 1.50 (1.02) | 0.81 (0.66) | 0.69 | 0.82 | 2.00 (1.08) | 1.60 (1.17) | 0.40 | 0.35 | |
| f | 6.150 | 0.028 | 0.002 | 0.970 | 6.415 | 0.025 | 1.75 (1.14) | 0.82 (0.87) | 0.93 | 0.92 | 1.82 (0.96) | 1.27 (1.19) | 0.55 | 0.51 | |
| BDI 22 | Total | 0.002 | 0.960 | 0.156 | 0.695 | 11.908 | 0.001 | 1.52 (1.16) | 1.11 (1.12) | 0.41 | 0.36 | 1.37 (1.20) | 1.55 (1.18) | – | – |
| m | 0.023 | 0.882 | 0.313 | 0.583 | 5.642 | 0.028 | 1.54 (1.06) | 0.94 (0.93) | 0.60 | 0.57 | 1.30 (1.13) | 1.55 (1.13) | – | – | |
| f | 0.526 | 0.481 | 0.775 | 0.395 | 0.114 | 0.741 | 1.50 (1.26) | 1.36 (1.36) | 0.14 | 0.11 | 1.43 (1.29) | 1.55 (1.29) | – | – | |
| HAMA 14 | Total | 0.131 | 0.720 | 0.779 | 0.283 | 2.412 | 0.128 | 1.19 (0.93) | 0.38 (0.62) | 0.81 | 1.04 | 1.07 (0.69) | 1.55 (4.64) | – | – |
| m | 2.839 | 0.109 | 0.489 | 0.493 | 6.301 | 0.022 | 1.29 (1.12) | 0.38 (0.62) | 0.91 | 1.26 | 0.95 (0.71) | 0.64 (0.81) | 0.31 | 0.41 | |
| f | 0.101 | 0.755 | 1.332 | 0.265 | 1.424 | 0.250 | 1.12 (0.78) | 0.38 (0.65) | 0.74 | 1.03 | 1.18 (0.66) | 2.45 (6.53) | – | – | |
| Ergo-Asses 3 | Total | 1.753 | 0.195 | 0.172 | 0.681 | 6.344 | 0.017 | 13.90 (3.51) | 10.96 (3.59) | 2.94 | 0.83 | 12.72 (5.12) | 11.90 (5.03) | 0.82 | 0.16 |
| m | 1.036 | 0.329 | 3.697 | 0.079 | 2.245 | 0.160 | 14.45 (4.12) | 11.92 (4.38) | 2.53 | 0.60 | 11.94 (5.49) | 9.70 (3.53) | 2.24 | 0.50 | |
| f | 0.667 | 0.429 | 3.089 | 0.102 | 2.210 | 0.161 | 13.50 (3.01) | 9.91 (2.21) | 3.59 | 1.38 | 13.38 (4.81) | 14.10 (5.49) | – | – | |
HAMD 19: depersonalization and derealization
BDI 15: loss of energy
BDI 16: disturbed sleep pattern
BDI 22: loss of sexual interest
HAMA 14: anxious behavior during interview
Ergo-Assess 3: basic work skills
GLM general linear model (controlled for age, IQ, axis-I/II comorbidity, number of psychoactive drugs and number of antidepressants), stratified for gender (m males, f females), M pre/post mean pre/post, SD standard deviation, ∆ difference between pre- and post-mean, ES effect size (Cohen’s d). HAMD Hamilton Depression Scale, BDI Beck Depression Inventory, HAMA Hamilton Anxiety Scale, Ergo-Assess™ German Occupational Therapy Assessment